Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 31, 2021Biomarker ResearchOpen Access

Novel strategies for immuno-oncology breakthroughs with cell therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

HLHongtao LiuUniversity of Wisconsin–MadisonCPChong-xian PanHarvard UniversityWSWenru SongAVEO Oncology (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Liu et al. (2021) studied this question.

synapsesocial.com/papers/6aa92fd4d0c7c778ac8cbaa3https://doi.org/10.1186/s40364-021-00316-6
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Chimeric Antigen Receptor T Cell Therapy: Challenges to Bench-to-Bedside Efficacy2018 · 225 citations
  2. 2AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody–Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML2015 · 97 citations
  3. 3Immune checkpoint inhibitors of PD-L1 as cancer therapeutics2019 · 790 citations
  4. 4PD-L1 chimeric costimulatory receptor improves the efficacy of CAR-T cells for PD-L1-positive solid tumors and reduces toxicity in vivo2020 · 23 citations
  5. 5Emerging therapies in mantle cell lymphoma2020 · 50 citations